Innovation
Roche regards lasting innovation as the company’s most important contribution to society
Our ongoing innovation covers many different areas including oncology, neuroscience, inflammation, immunology, ophthalmology, rare diseases, cardiovascular disease, respiratory diseases and diabetes.
Our vision is to work towards truly personalised medicine, where every patient receives individualised treatment to improve their health outcomes. By embracing the most advanced technology and utilising our invaluable partnerships, Roche harnesses the power of our unique network to advance and develop new therapies and diagnostic tests.
:quality(90)/)
:quality(90)/)
What we are working on
Driving Digital Diagnostics
:quality(90)/)
Accelerating and improving individualised treatment options for cancer and critical care patients through the development of digital clinical decision-making solutions is at the core of our strategic, long term partnership with GE Healthcare.
Real-World Health Analytics
:quality(90)/)
Roche subsidiary, Flatiron Health, is driving personalised healthcare and pioneering the curation and development of real-world evidence in cancer research thanks to our leadership in data analytics.
Piloting tele-trials in Australia
:quality(90)/)
Roche is piloting a number of tele-trials in Australia, including one for lung cancer. The tele-trial model uses tele-health to enable clinicians from larger centres (primary sites) to enrol, consent and treat patients on clinical trials at regional and rural centres (satellite sites).